Futura Medical plc (FUM.L)
- Previous Close
8.94 - Open
0.00 - Bid 8.76 x --
- Ask --
- Day's Range
0.00 - 0.00 - 52 Week Range
0.00 - 45.56 - Volume
327 - Avg. Volume
515,882 - Market Cap (intraday)
26.555M - Beta (5Y Monthly) 0.99
- PE Ratio (TTM)
∞ - EPS (TTM)
0.00 - Earnings Date Apr 15, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
100.00
Futura Medical plc research, develops, and sells pharmaceutical and healthcare products for sexual health. Its lead product is Eroxon, a topical gel for the treatment of erectile dysfunction. Futura Medical plc was incorporated in 2001 and is headquartered in Guildford, the United Kingdom.
www.futuramedical.comRecent News: FUM.L
View MorePerformance Overview: FUM.L
Trailing total returns as of 5/6/2025, which may include dividends or other distributions. Benchmark is FTSE 100 (^FTSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: FUM.L
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: FUM.L
View MoreValuation Measures
Market Cap
27.16M
Enterprise Value
20.57M
Trailing P/E
21.80
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.00
Price/Book (mrq)
3.03
Enterprise Value/Revenue
1.48
Enterprise Value/EBITDA
15.06
Financial Highlights
Profitability and Income Statement
Profit Margin
9.28%
Return on Assets (ttm)
6.12%
Return on Equity (ttm)
17.91%
Revenue (ttm)
13.93M
Net Income Avi to Common (ttm)
1.29M
Diluted EPS (ttm)
0.00
Balance Sheet and Cash Flow
Total Cash (mrq)
6.6M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-2.59M